TRAVERE THERAPEUTICS, INC. Stock Repurchased During Period, Value
Shares the company repurchased and the cash it paid, as filed in its 10-Q and 10-K XBRL (statement of shareholders' equity and cash flow statement).
- TRAVERE THERAPEUTICS, INC. stock repurchased during period, value for the quarter ending 2014-12-31 was $4.52M.
- TRAVERE THERAPEUTICS, INC. stock repurchased during period, value for fiscal 2015 was $3.20M, a 41.72% increase from fiscal 2014.
- TRAVERE THERAPEUTICS, INC. stock repurchased during period, value for fiscal 2014 was $2.26M, a 135.95% increase from fiscal 2013.
- TRAVERE THERAPEUTICS, INC. stock repurchased during period, value for fiscal 2013 was $957.00K.
| Period end | Stock Repurchased During Period, Value 3 month | Stock Repurchased During Period, Value 12 month |
|---|---|---|
| 2015-12-31 | $3.20M 10-K · filed 2018-07-06 | |
| 2014-12-31 | $4.52M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-01 | $2.26M 10-K · filed 2017-03-01 |
| 2013-12-31 | $957.00K 10-K · filed 2016-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Cogent Biosciences, Inc. (COGT) | United States | $5.450B | -17.61 |
| Gossamer Bio, Inc. (GOSS) | United States | $5.355B | -0.65 |
| PTC THERAPEUTICS, INC. (PTCT) | United States | $5.199B | -177.07 |
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| Dianthus Therapeutics, Inc. /DE/ (DNTH) | United States | $5.082B | -27.79 |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| Erasca, Inc. (ERAS) | United States | $5.073B | -19.96 |
| Veradermics, Inc (MANE) | United States | $4.839B |